Trials / Completed
CompletedNCT00830713
Vitiligo Skin Transplantation
Safety and Efficacy of Melanocyte-keratinocyte Transplantation in the Treatment of Vitiligo
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Henry Ford Health System · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In vitiligo, the melanocytes are lost from the skin in certain areas. One treatment for vitiligo takes the melanocytes from areas of normal skin and places them on areas of that same person's body which have lost their color. This is called the melanocyte-keratinocyte transplantation procedure (MKTP). This procedure has been used successfully in over 3000 cases in India and Saudi Arabia. The purpose of this study is to see if it is effective when performed at the investigators' institution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Melanocyte-keratinocyte transplantation procedure (MKTP) | skin pigment cells are taken from areas of normal skin and placed on areas of that same person's body which have lost their color. |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2009-01-28
- Last updated
- 2012-09-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00830713. Inclusion in this directory is not an endorsement.